A new Covid variant, designated BA.3.2, is rapidly spreading across the United States and may possess the ability to evade protection offered by current vaccines. First detected in South Africa in 2024 and subsequently identified in the US in June 2025, this variant has now been found in clinical samples, traveller swabs, and wastewater across more than 20 states.
Genetic Changes and Vaccine Evasion
BA.3.2 exhibits between 70 to 75 genetic changes in its spike protein, a critical component that the virus uses to enter human cells. Laboratory studies indicate that these mutations enable the variant to potentially bypass antibodies activated by existing Covid vaccines.
Impact on Current Vaccines
Research has shown that the 2025–2026 LP.8.1-adapted mRNA Covid-19 vaccine demonstrated the lowest level of antibody neutralisation against BA.3.2 when compared to other circulating variants. This suggests that current immunisation strategies may be less effective against this new strain.
Current Situation and Monitoring
While BA.3.2 is not yet the dominant variant in the US and detected cases have not shown increased severity, scientists are emphasising the importance of continuous monitoring. The virus's ability to mutate necessitates adaptive public health responses to mitigate potential risks.
Health authorities are urging vigilance as the variant continues to spread, highlighting the need for updated vaccines and booster shots to address evolving viral threats. The situation underscores the ongoing challenge of managing Covid-19 in a post-pandemic era.
